Lion raises $100M, names new CEO

Cancer immunotherapy company Lion Biotechnologies Inc. (NASDAQ:LBIO) raised $100 million in a private placement led by Quogue Capital, OrbiMed,

Read the full 193 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE